Fluorinated Peptide Hydrogels Result in Longer <i>In Vivo</i> Residence Time after Subcutaneous Administration-Reference-Cited by-同舟云学术

Fluorinated Peptide Hydrogels Result in Longer In Vivo Residence Time after Subcutaneous Administration

Published:2024-09-04 Issue: Volume: Page:
ISSN:1525-7797
Container-title:Biomacromolecules
language:en
Short-container-title:Biomacromolecules

Author:

Honfroy Aurélie¹²³⁴,Bertouille Jolien¹^ORCID,Turea Ana-Maria¹,Cauwenbergh Thibault¹,Bridoux Jessica²,Lensen Nathalie³⁴,Mangialetto Jessica⁵^ORCID,Van den Brande Niko⁵,White Jacinta F.⁶,Gardiner James⁶^ORCID,Brigaud Thierry³⁴^ORCID,Ballet Steven¹^ORCID,Hernot Sophie²,Chaume Grégory³⁴,Martin Charlotte¹

Affiliation:

1. Research Group of Organic Chemistry (ORGC), Vrije Universiteit Brussel, Pleinlaan 2, Brussels B-1050, Belgium

2. VUB, Molecular Imaging and Therapy Research Group (MITH), Laarbeeklaan 103, Jette 1090, Belgium

3. CY Cergy Paris Université, CNRS, BioCIS UMR 8076, Cergy-Pontoise 95000, France

4. Université Paris-Saclay, CNRS, BioCIS UMR 8076, Orsay 91400, France

5. Research Group Sustainable Materials Engineering (SUME), Lab of Physical Chemistry and Polymer Science (FYSC), Vrije Universiteit Brussel, Pleinlaan 2, Brussels B-1050, Belgium

6. CSIRO Manufacturing, Bayview Avenue, Clayton, VIC 3169, Australia

Funder

Agence Nationale de la Recherche

Vrije Universiteit Brussel

Fonds Wetenschappelijk Onderzoek

Eutopia Foundation

Publisher

American Chemical Society (ACS)

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.biomac.4c00872

Reference82 articles.

1. The evolution of commercial drug delivery technologies

2. Controlled Drug Delivery Systems: Current Status and Future Directions

3. Clinical translation of long-acting drug delivery formulations

4. Controlled-release of opioids for improved pain management

5. Overview of Oral Modified-Release Opioid Products for the Management of Chronic Pain